9/12/2022CFIUS Derails Asymchem's Acquisition of Snapdragon

9/12/2022Biden Signs Executive Order to Boost US Biotechnology and Cut Relian...

9/9/2022CDE Solicits Comments on Draft Technical Guidelines for Continuous Man...

9/9/2022Recent Executive Moves

9/7/2022Vision Forward Remains Blurry for Chinese Economy and Healthcare Secto...

9/6/2022A Share-Listed Chinese Pharma Cos Report Performance in H1/2022

9/6/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...

9/6/2022NHSA Publicizes the List of Drugs Passing Preliminary Form Evaluation ...

9/5/2022Debt-Strapped Fosun Intl to Pare Stakes in Listed Subsidiaries Includi...

9/2/2022PharmaLex Group Opens New Offices in China

9/2/2022NHC: China Completes Initial Phase of National Health Information Plat...

9/2/2022SAMR Issues New Regulation on Online Drug Sales (with Summary)

9/2/2022Recent Official and Executive Moves

9/2/2022Targeting Novo Nordisk in China's Obesity Market with A Unique Proposi...

9/1/2022Why Genentech Eyes on Jemincare's Androgen Receptor Degrader?

9/1/2022NMPA and Chinese Customs Announce Addition of Shijiazhuang Airport as ...

8/31/2022Mayo Clinic, Hibiscus and Innoforce Announce Mayflower Cell and Gene T...

8/31/2022Financial-related Company News Digest (August 2022)

8/31/2022IQVIA: Chinese Hospital Drug Market Down 5.8% in Q2/2022

8/31/2022Snapshot of Top Ten Drug Products by Representative Hospital Sales in ...

8/30/2022USCBC 2022 Member Survey: China's COVID-19 Policies Are the Top Chall...

8/30/2022RoosterBio and MBL Beijing Biotech Partner to Accelerate Advanced Ther...

8/29/2022Porton Advanced, Royaltech Accelerate Development of mRNA Drugs in Chi...

8/26/2022NMPA Announces OTC Switch of Omeprazole Enteric-Coated Tablets

8/26/2022Recent Official and Executive Moves

8/24/2022NMPA Suspends Import, Sales and Use of UCB's Epilepsy Drug Keppra

8/22/2022Drug R&D and Approvals in China – July Update on YouTube (PharmCube)

8/22/2022New Rational Drug Use Rules in China Benefit Pediatric, Anti-Tumor And...

8/19/2022Lundbeck Fails China Trial for CGRP Migraine Drug Vyepti, Undermining ...

8/18/2022Roche to Pay $60M Upfront in License Deal for Jemincare's Potential Pr...

Page:61/356 Total number of articles:10671: [First][<<] [59] [60] [61] [62] [63] [>>] [End]